Minister highlights RDI fund, private participation in space and nuclear sectors, and calls for faster reforms to improve ease of research in India
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
API maker begins circulation of second and final call money notice for partly paid-up rights shares, completing the last leg of its 2024 fundraising cycle
Opioid dependence remains a major driver of death and disease worldwide
The new capital is expected to fund the company through 2029
New filtration lines will boost global drug supply and strengthen India’s role in Merck’s manufacturing network
Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Subscribe To Our Newsletter & Stay Updated
